Mersana Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NEXTECH INVEST LTD. | 02/14/2025 | 12.07 M | $17.26 M | 0.00% | 9.83% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 11.33 M | $16.20 M | -41.50% | 9.23% |
| VR ADVISER, LLC | 02/14/2025 | 10.26 M | $14.67 M | -9.45% | 8.36% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 9.21 M | $13.16 M | 6.77% | 7.50% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 8.66 M | $12.39 M | 0.00% | 7.06% |
| VANGUARD GROUP INC | 02/11/2025 | 7.06 M | $10.09 M | -1.67% | 5.75% |
| NOVO HOLDINGS A/S | 02/14/2025 | 4.25 M | $6.08 M | 100.00% | 3.46% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 3.43 M | $4.91 M | 12.63% | 2.80% |
| 02/14/2025 | 2.64 M | $3.77 M | 100.00% | 2.15% | |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.53 M | $3.62 M | 7.79% | 2.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 2.44 M | $3.49 M | 1.20% | 1.99% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 2.12 M | $3.03 M | -4.67% | 1.73% |
| 02/14/2025 | 1.71 M | $2.44 M | 100.00% | 1.39% | |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 1.31 M | $1.87 M | 0.00% | 1.06% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 1.12 M | $1.60 M | -6.63% | 0.91% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.09 M | $1.55 M | 0.00% | 0.89% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 992,000 | $1.42 M | 0.00% | 0.81% |
| 683 CAPITAL MANAGEMENT, LLC | 02/14/2025 | 900,000 | $1.29 M | 392.36% | 0.73% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 839,724 | $1.20 M | -47.39% | 0.68% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 802,366 | $1.15 M | -59.05% | 0.65% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 795,973 | $1.14 M | 206.40% | 0.65% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 690,272 | $987,089 | 100.00% | 0.56% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 606,285 | $866,988 | 23.05% | 0.49% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 576,148 | $823,891 | -6.82% | 0.47% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 544,463 | $778,582 | -46.75% | 0.44% |
| HEALTHINVEST PARTNERS AB | 02/04/2025 | 538,621 | $764,842 | 0.00% | 0.44% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 508,296 | $727,000 | 87.03% | 0.41% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 448,000 | $640,640 | -7.97% | 0.37% |
| WOODLINE PARTNERS LP | 02/14/2025 | 435,593 | $622,898 | 0.47% | 0.35% |
| UBS OCONNOR LLC | 02/14/2025 | 410,029 | $586,341 | -28.07% | 0.33% |
| JANE STREET GROUP, LLC | 02/14/2025 | 383,200 | $547,976 | 0.00% | 0.31% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 361,147 | $516,440 | 52.26% | 0.29% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 347,415 | $496,803 | -60.39% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 346,189 | $495,050 | -6.98% | 0.28% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 336,806 | $481,633 | -74.16% | 0.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 312,623 | $447,051 | 0.00% | 0.25% |
| FMR LLC | 02/13/2025 | 299,324 | $428,034 | 7.77% | 0.24% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 239,685 | $342,750 | 2.78% | 0.20% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 232,223 | $332,079 | 53.59% | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 210,876 | $301,553 | -29.76% | 0.17% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 02/12/2025 | 194,153 | $278,000 | 100.00% | 0.16% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 186,060 | $266,066 | 0.00% | 0.15% |
| FEDERATED HERMES, INC. | 02/13/2025 | 183,723 | $262,724 | -0.01% | 0.15% |
| BARCLAYS PLC | 02/13/2025 | 182,711 | $262,000 | -63.05% | 0.15% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 172,924 | $249,723 | -85.33% | 0.14% |
| RHUMBLINE ADVISERS | 01/30/2025 | 171,857 | $245,741 | 3.00% | 0.14% |
| UBS GROUP AG | 02/14/2025 | 162,264 | $232,037 | -65.73% | 0.13% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 159,760 | $228,457 | -15.77% | 0.13% |
| JANE STREET GROUP, LLC | 02/14/2025 | 151,526 | $216,681 | -63.70% | 0.12% |
| MACQUARIE GROUP LTD | 02/14/2025 | 150,000 | $215,000 | 0.00% | 0.12% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mersana Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 153 institutional investors and hedge funds held shares of Mersana Therapeutics, Inc.. The most heavily invested institutionals were:
Nextech Invest Ltd.: 12.07 M
EcoR1 Capital, LLC: 11.33 M
VR Adviser, LLC: 10.26 M
BlackRock Funding, Inc. /DE: 9.21 M
Bain Capital Life Sciences Investors, LLC: 8.66 M
VANGUARD GROUP INC: 7.06 M
84.98% of Mersana Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 118.09 M shares in the last 24 months. This purchase volume represents approximately $160.60 M in transactions.